Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Raynaud's syndrome.

× No keyword cloud information.

37 in total

1. Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis.

Authors: M Rademaker; R H Thomas; G Provost; J A Beacham; E D Cooke; J D Kirby
Journal: Postgrad Med J Date: 1987-08 Impact factor: 2.401

2. Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.

Authors: N J McHugh; M Csuka; H Watson; G Belcher; A Amadi; E F Ring; C M Black; P J Maddison
Journal: Ann Rheum Dis Date: 1988-01 Impact factor: 19.103

3. Selective antagonism of S2-serotonergic receptors relieves but does not prevent cold induced vasoconstriction in primary Raynaud's phenomenon.

Authors: J R Seibold; C A Terregino
Journal: J Rheumatol Date: 1986-04 Impact factor: 4.666

4. The effect of captopril on cutaneous blood flow in patients with primary Raynaud's phenomenon.

Authors: M H Rustin; N E Almond; J A Beacham; R J Brooks; D P Jones; E D Cooke; P M Dowd
Journal: Br J Dermatol Date: 1987-12 Impact factor: 9.302

5. Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders.

Authors: O K Roald; E Seem
Journal: Br Med J (Clin Res Ed) Date: 1984-09-08

6. Role of cold and emotional stress in Raynaud's disease and scleroderma.

Authors: R R Freedman; P Ianni
Journal: Br Med J (Clin Res Ed) Date: 1983-11-19

7. Endothelium-dependent relaxation of rabbit aorta. I. Relaxation stimulated by arachidonic acid.

Authors: H A Singer; M J Peach
Journal: J Pharmacol Exp Ther Date: 1983-09 Impact factor: 4.030

8. Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis.

Authors: R H Meyrick Thomas; M Rademaker; S M Grimes; A MacKay; I B Kovacs; E D Cook; S M Bowcock; J D Kirby
Journal: Br J Dermatol Date: 1987-08 Impact factor: 9.302

9. Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid.

Authors: S Fischer; P C Weber
Journal: Nature Date: 1984 Jan 12-18 Impact factor: 49.962

10. Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5 omega 3).

Authors: S Fischer; P C Weber
Journal: Biochem Biophys Res Commun Date: 1983-11-15 Impact factor: 3.575

4 in total

1. Once daily felodipine in patients with primary Raynaud's phenomenon.

Authors: C G Kallenberg; A A Wouda; L Meems; H Wesseling
Journal: Eur J Clin Pharmacol Date: 1991 Impact factor: 2.953

2. Increased capillary permeability in systemic sclerosis: help or hindrance?

Authors: W Grassi; P Core; C Cervini
Journal: Ann Rheum Dis Date: 1996-09 Impact factor: 19.103

3. Raynaud's syndrome.

Authors: V F Challenor; K Donaldson; D G Waller
Journal: BMJ Date: 1990-04-14

4. Raynaud's syndrome.

Authors: R R Freedman
Journal: BMJ Date: 1990-04-28

4 in total